ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,346.99
-0.11%
Dow Jones
38,798.99
-0.22%
US Dollar vs MXN
18.4136
0.00%
Brent Oil
79.395
0.00%
Bitcoin
69,355.29
0.03%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Loxo Oncology, Inc. (LOXO)

  7. Loxo Oncology, Inc. (LOXO) Noticias

LOXO

LOXO ONCOLOGY, INC. (LOXO)

Loxo Oncology, Inc.
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:LOXO
FechaHoraFuenteTítuloSímboloCompañía
14/02/202011:55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:LOXOLoxo Oncology, Inc.
08/01/202014:11Edgar (US Regulatory)Schedule 13gNASDAQ:LOXOLoxo Oncology, Inc.
25/02/201910:29Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:LOXOLoxo Oncology, Inc.
22/02/201905:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201915:56Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201915:43Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201915:41Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201915:39Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201915:07Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201908:24Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201908:23PR Newswire (US)Lilly Completes Acquisition of Loxo OncologyNASDAQ:LOXOLoxo Oncology, Inc.
15/02/201908:22Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201908:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201908:16Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:LOXOLoxo Oncology, Inc.
06/02/201906:48Dow Jones NewsEli Lilly Cuts Earnings Forecast on Pending Loxo AcquisitionNASDAQ:LOXOLoxo Oncology, Inc.
01/02/201905:45GlobeNewswire Inc.Lilly and Loxo Oncology Announce Expiration of HSR Act Waiting Period in Connection with Proposed TransactionNASDAQ:LOXOLoxo Oncology, Inc.
17/01/201907:09Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:LOXOLoxo Oncology, Inc.
17/01/201906:38Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:LOXOLoxo Oncology, Inc.
17/01/201906:37Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:LOXOLoxo Oncology, Inc.
15/01/201915:09Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:LOXOLoxo Oncology, Inc.
11/01/201909:10PR Newswire (US)Financialinsiders.com: 'Indexes Rise' Market News Recap Week Ending January 11th, 2019NASDAQ:LOXOLoxo Oncology, Inc.
08/01/201916:09Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:LOXOLoxo Oncology, Inc.
08/01/201914:12PR Newswire (US)WEISSLAW LLP: Loxo Oncology, Inc. Acquisition May Not Be In The Best Interests of LOXO ShareholdersNASDAQ:LOXOLoxo Oncology, Inc.
08/01/201902:02Dow Jones NewsLilly's Deal Boosts Its Cancer Arsenal -- WSJNASDAQ:LOXOLoxo Oncology, Inc.
07/01/201916:12PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Loxo Oncology, Inc.NASDAQ:LOXOLoxo Oncology, Inc.
07/01/201916:10Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:LOXOLoxo Oncology, Inc.
07/01/201915:44Dow Jones NewsU.S. Stocks Rise as U.S.-China Trade Talks Kick OffNASDAQ:LOXOLoxo Oncology, Inc.
07/01/201915:03Dow Jones NewsEli Lilly to Buy Loxo Oncology in $8 Billion Deal -- 5th UpdateNASDAQ:LOXOLoxo Oncology, Inc.
07/01/201913:58Dow Jones NewsU.S. Stocks Mixed as U.S.-China Trade Talks Kick OffNASDAQ:LOXOLoxo Oncology, Inc.
07/01/201907:47Dow Jones NewsEli Lilly to Buy Loxo Oncology in $8 Billion Deal--4th UpdateNASDAQ:LOXOLoxo Oncology, Inc.
 Showing the most relevant articles for your search:NASDAQ:LOXO

Su Consulta Reciente

USOTC
BASFY
BASF (QX)
USOTC
ADDYY
Adidas (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
SPY
SPDR S&P 500
USI
USTECH100
US Tech 100
NYSE
BAC
Bank of America
CCOM
OILBRENT
Brent Oil
NYSE
AXP
American Express
FX
EURUSD
Euro vs US Dollar
NYSE
CVX
Chevron
CCOM
SILVER
SILVER
COIN
SOLUSD
Solana
PM
XAUUSD
Gold vs US Dollar
FX
USDMXN
US Dollar vs MXN
NASDAQ
TSLA
Tesla
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados